Crossmark

Evaluation of dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for predicting muscular hyperplasia/hypertrophy in Crohn’s disease

Crossref DOI link: https://doi.org/10.1007/s00261-022-03422-7

Published Online: 2022-03-04

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Lin

Hu, Shun

Huang, Fu-Chen

Wu, Yin-Chen

Zheng, Xian-Ying https://orcid.org/0000-0001-7261-9177
Funding

Funding for this research was provided by:

Startup Fund for Scientific Research of Fujian Medical University (No. 2018QH1054)
License Information

Text and Data Mining valid from 2022-03-04

Version of Record valid from 2022-03-04
More Information

Article History

Received: 1 November 2021

Revised: 12 January 2022

Accepted: 13 January 2022

First Online: 4 March 2022

Declarations

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

: The study was reviewed and approved by the Branch for Medical Research and Clinical Technology Application, Ethics Committee of First Affiliated Hospital of Fujian Medical University.

: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.

Document is current

Any future updates will be listed below